Abstract
We report a rare case of a suspected inflammatory reaction to stored fascia lata 37 years post-placement. Clinical, imaging, histopathological, and immunohistochemical findings are presented, with a literature review on reactions to stored fascia lata. A 39-year-old woman had upper eyelid congenital ptosis repaired successfully at 2 years with bilateral frontalis suspension procedures using stored fascia lata. Thirty-seven years later, the patient presented with swelling of her eyelids and forehead, which was tender to the touch, in the same pattern as the fascia lata slings placed earlier. Histopathological examination disclosed a non-necrotizing granulomatous inflammatory infiltrate with numerous asteroid bodies. Initially, it was responsive to oral prednisone, but with recurrent inflammation, long-term methotrexate was required to control the inflammation. To our knowledge, this type of delayed inflammatory reaction has not been previously reported. It raises a concern about the use of allogeneic donor tissue and accepted sterilization techniques that may not be 100% effective in deactivating all components of the donor graft, including potential infectious pathogens, leading to a subsequent latent reaction.
References
1.
Esmaeli
B
, Chung
H
, Pashby
RC
. Long-term results of frontalis suspension using irradiated, banked fascia lata
. Ophthal Plast Reconstr Surg
. 1998
;14
(3
):159
–63
. .2.
Bedrossian
EH
. HIV and banked fascia lata
. Ophthal Plast Reconstr Surg
. 1991
;7
(4
):284
–8
. .3.
Tanji
TM
, Lundy
DC
, Minckler
DS
, Heuer
DK
, Varma
R
. Fascia lata patch graft in glaucoma tube surgery
. Ophthalmology
. 1996
;103
(8
):1309
–12
. .4.
O’Reilly
J
, Lanigan
B
, Bowell
R
, O’Keefe
M
. Congenital ptosis: long-term results using stored fascia lata
. Acta Ophthalmol Scand
. 1998
;76
:346
–8
.5.
Wasserman
BN
, Sprunger
DT
, Helveston
EM
. Comparison of materials used in frontalis suspension
. Arch Ophthalmol
. 2001
;119
(5
):687
–91
. .6.
Hersh
D
, Martin
FJ
, Rowe
N
. Comparison of silastic and banked fascia lata in pediatric frontalis suspension
. J Pediatr Ophthalmol Strabismus
. 2006
;43
(4
):212
–8
. .7.
Crawford
JS
. Repair of ptosis using frontalis muscle and fascia lata: a 20-year review
. Ophthalmic Surg
. 1977
;8
(4
):31
–40
.8.
Ahmadi
AJ
, Sires
BS
. Ptosis in infants and children
. Int Ophthalmol Clin
. 2002
;42
(2
):15
–29
. .9.
Crawford
JS
. Frontalis sling operation
. J Ped Ophthalmol Stabismus
. 1982
;19
(5
):253
–5
.10.
Wagner
RS
, Mauriello
JA
, Nelson
LB
, Calhoun
JH
, Flanagan
JC
, Harley
RD
. Treatment of congenital ptosis with frontalis suspension: a comparison of suspensory materials
. Ophthalmology
. 1984
;91
(3
):245
–8
. .11.
Beyer
CK
, Albert
DM
. The use and fate of fascia lata and sclera in ophthalmic plastic and reconstructive surgery. The 1980 wendall hughes lecture
. Ophthalmology
. 1981
;88
:869
–86
.12.
Lee
J
, Lee
H
, Chang
M
, Park
M
, Baek
S
. Clinical results of modified frontalis suspension technique using preserved fascia lata for congenital ptosis
. J Craniofac Surg
. 2016
;27
(5
):e477
–81
. .13.
Wilson
ME
, Johnson
RW
. Congenital ptosis. Long-term results of treatment using lyophilized fascia lata for frontalis suspensions
. Ophthalmology
. 1991
;98
(8
):1234
–7
. .14.
Whitehouse
GM
, Grigg
JR
, Martin
FJ
. Congenital ptosis: results of surgical management
. Aust N Z J Ophthalmol
. 1995
;23
(4
):309
–14
. .15.
Broughton
WL
, Matthews
JG
, Harris
DJ
. Congenital ptosis. Results of treatment using lyophilized fascia lata for frontalis suspensions
. Ophthalmology
. 1982
;89
(11
):1261
–6
. .16.
Orlando
F
, Weiss
JS
, Beyer-Machule
CK
, Albert
DM
, Shapiro
A
. Histopathologic condition of fascia lata implant 42 years after ptosis repair
. Arch Ophthalmol
. 1985
;103
(10
):1518
–9
. .17.
Gutman
FA
. Sterilization with cobalt radiation of fascia lata for homotransplant
. AM J Ophthalmol
. 1965
;59
:1095
–8
. .18.
Townsend
AL
, Crawford
JS
. Stored fascia lata for ophthalmic surgery
. Can J Ophthalmol
. 1969
;4
(4
):331
–8
.19.
Nunnery
WR
. Risk of prion transmission with the use of xenografts and allografts in surgery
. Ophthal Plast Reconstr Surg
. 2001
;17
(6
):389
–94
.20.
Tan
L
, Williams
M
, Khan
MK
. Risk of transmission of bovine spongiform encephalopathy to humans in the United States: report of the council on scientific affairs. American medical association
. JAMA
. 1999
;281
:2330
–9
.21.
Pruisiner
SB
. Genetic and infectious prion diseases
. Arch Neurol
. 1993
;50
(11
):1129
–53
.22.
Memoranda. World Health Organization
. Medicinal and other products and human and animal transmissible spongiform encephalopathies: memorandum from a WHO meeting
. Bull World Health Organ
. 1997
;75
(6
):505
–13
.23.
Darbord
JC
. Inactivation of prions in daily medical practice
. Biomed Pharmacother
. 1999
;53
(1
):34
–8
.24.
Budka
H
, Aguzze
A
, Brown
P
, Brucher
JM
, Bugiani
O
, Collinge
J
, et al. Tissue handling in suspected Creutzfeldt-Jacob disease (CJD) and other human spongiform encephalopathies (prion disease)
. Brain Pathol
. 1995
;5
:319
–22
.© 2021 S. Karger AG, Basel
2021
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
